Pharmacy - Postgraduate Research Projects
Currently available projects
Molecular Investigations Tumour-Initiating Populations of Melanoma Cells for Clinical Applications
- School:
Pharmacy
- Primary Supervisor:
Dr Vicky Sherwood
Information
- Start date: October 2013
- Programme: PhD
- Mode of Study: Full Time
- Studentship Length: 3 years
How to Apply
- Deadline: 31 July 2013. Applications are processed as soon as they are received, so early application is encouraged. NB applicants who wish to start their studies in October 2013 should submit their application by 31 July 2013 at the very latest. Applications received after this date will be considered for the January 2014 entry point if the project is still available.
- Apply online
Fees & Funding
- Funding Status: Self-Funded Students Only
Further Details - Fees: Fees Information (Opens in new window)
- Bench Fees: £1500
Entry Requirements
- Acceptable First Degree:
Any biology-related subject
- Minimum Entry Standard: 2:1
Project Description
It is a goal of cancer researchers to identify the most aggressive subpopulations of tumour cells for the development of novel therapeutics for patients with advanced stage disease. However, current approaches to identify and isolate these tumour-initiating subpopulations of tumour cells are extremely varied, and this has limited the ability of researchers to determine universal markers of such subpopulations for a variety of cancers. Cutaneous melanoma is an example of a malignancy where there is much debate over the identity of tumour-initiating cancer cells and there is a lack of well-defined cell surface markers to consistently identify these subpopulations in tumours. It is becoming increasingly apparent that tumour-initiating cells are not a fixed population, but rather their tumour-initiating phenotype can be heavily influenced by the tumour microenvironment. Growing melanoma cells in 3D culturing conditions provides an artificial environment that can select for tumour-initiating phenotypes. Here we shall circumvent the requirement of robust markers for isolating tumour-initiating subpopulations from genetically-diverse melanomas, by culturing cells in 3D conditions. Cells isolated from these conditions will be used to investigate the behaviour of these cells and identify novel biomarkers of highly aggressive subpopulations of tumour cells.
Apply online


